Bleichroeder LP Eye Point Pharmaceuticals, Inc. Call Options Transaction History
Bleichroeder LP
- $315 Million
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding EYPT
# of Institutions
163Shares Held
67.2MCall Options Held
214KPut Options Held
994K-
Cormorant Asset Management, LP Boston, MA8.33MShares$101 Million7.9% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.8MShares$82.5 Million2.2% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA6.8MShares$82.4 Million0.11% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA4.6MShares$55.7 Million0.09% of portfolio
-
Franklin Resources Inc San Mateo, CA4.3MShares$52.1 Million0.01% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $413M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...